Literature DB >> 21680764

Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Elisabeth Nagy1, Simone Becker2, József Sóki1, Edit Urbán1, Markus Kostrzewa2.   

Abstract

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) is increasingly used in clinical microbiological laboratories to identify bacteria and fungi at a species level and to subtype them. The cfiA gene encoding the unique carbapenemases found in Bacteroides is restricted to division II Bacteroides fragilis strains. The aim of this study was to evaluate whether MALDI-TOF MS is suitable for differentiating B. fragilis strains which harbour the cfiA gene from those that do not. A well-defined collection of 40 B. fragilis isolates with known imipenem MICs (0.062->32 mg l(-1)) were selected for this study. Twelve B. fragilis strains with known cfiA status, including NCTC 9343 (division I) and TAL3636 (division II), were measured by means of microflex LT MALDI-TOF MS and well-defined differences in mass spectra between the cfiA-positive and cfiA-negative strains were found in the interval 4000-5500 Da. A further 28 strains were selected for the blind measurements: 9 cfiA-positive clinical isolates with different imipenem MICs ranging between 0.06 and >32 mg l(-1) (different expressions of the metallo-β-lactamase gene) were clearly separated from the 19 cfiA-negative isolates. The presence or absence of the selected peaks in all tested strains clearly differentiated the strains belonging to B. fragilis division I (cfiA-negative) or division II (cfiA-positive). These results suggest a realistic method for differentiating division II B. fragilis strains (harbouring the cfiA gene) and to determine them at a species level at the same time. Although not all cfiA-positive B. fragilis strains are resistant to carbapenems, they all have the possibility of becoming resistant to this group of antibiotics by acquisition of an appropriate IS element for full expression of the cfiA gene, leading to possible treatment failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680764     DOI: 10.1099/jmm.0.031336-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  29 in total

Review 1.  Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories.

Authors:  Alex van Belkum; Martin Welker; Marcel Erhard; Sonia Chatellier
Journal:  J Clin Microbiol       Date:  2012-02-22       Impact factor: 5.948

2.  Rapid detection of antibiotic resistance based on mass spectrometry and stable isotopes.

Authors:  J S Jung; T Eberl; K Sparbier; C Lange; M Kostrzewa; S Schubert; A Wieser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-14       Impact factor: 3.267

Review 3.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology.

Authors:  Andrew E Clark; Erin J Kaleta; Amit Arora; Donna M Wolk
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 4.  Antianaerobic antimicrobials: spectrum and susceptibility testing.

Authors:  Itzhak Brook; Hannah M Wexler; Ellie J C Goldstein
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  Efficient Detection of Carbapenemase Activity in Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Less Than 30 Minutes.

Authors:  Camille Lasserre; Luc De Saint Martin; Gaelle Cuzon; Pierre Bogaerts; Estelle Lamar; Youri Glupczynski; Thierry Naas; Didier Tandé
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

Review 6.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for the Rapid Detection of Antimicrobial Resistance Mechanisms and Beyond.

Authors:  Marina Oviaño; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

Review 7.  MALDI-TOF mass spectrometry technology for detecting biomarkers of antimicrobial resistance: current achievements and future perspectives.

Authors:  Georgia Vrioni; Constantinos Tsiamis; George Oikonomidis; Kalliopi Theodoridou; Violeta Kapsimali; Athanasios Tsakris
Journal:  Ann Transl Med       Date:  2018-06

8.  A Novel Selective Medium for Isolation of Bacteroides fragilis from Clinical Specimens.

Authors:  Pak-Leung Ho; Lok-Yan Ho; Chong-Yee Yau; Man-Ki Tong; Kin-Hung Chow
Journal:  J Clin Microbiol       Date:  2016-11-16       Impact factor: 5.948

9.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics.

Authors:  Katrin Sparbier; Sören Schubert; Ulrich Weller; Christiane Boogen; Markus Kostrzewa
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

10.  Occurrence of the p019 Gene in the blaKPC-Harboring Plasmids: Adverse Clinical Impact for Direct Tracking of KPC-Producing Klebsiella pneumoniae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  Eva Gato; Ignacio Pedro Constanso; Bruno Kotska Rodiño-Janeiro; Paula Guijarro-Sánchez; Tyler Alioto; Manuel Jesús Arroyo; Gema Méndez; Luis Mancera; Marta Gut; Ivo Gut; Miguel Álvarez-Tejado; Germán Bou; Marina Oviaño
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.